Citation: M. Barton, Postmenopausal oestrogen replacement therapy and atherosclerosis: can current compounds provide cardiovascular protection?, EXPERT OP I, 10(5), 2001, pp. 789-809
Authors:
Milosevich, Z
Vardaci, E
DeYoung, PA
Brown, CM
Kaplan, M
Whitfield, JP
Peterson, D
Dykstra, C
Barton, M
Karol, PJ
McMahan, MA
Citation: Z. Milosevich et al., Small angle particle-particle correlation measurements in the reactions 280 MeV Ar-40+Al-27 and 670 MeV Mn-55+C-12, NUCL PHYS A, 686, 2001, pp. 525-536
Citation: M. Barton et B. Glodny, Endothelin receptor blockade and nitric oxide bioactivity - [Cardiovascular Research 2001;49:146-151], CARDIO RES, 52(1), 2001, pp. 161-163
Authors:
Duru, F
Barton, M
Luscher, TF
Candinas, R
Citation: F. Duru et al., Endothelin and cardiac arrhythmias: do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs?, CARDIO RES, 49(2), 2001, pp. 272-280
Authors:
Goettsch, W
Lattmann, T
Amann, K
Szibor, M
Morawietz, H
Munter, K
Muller, SP
Shaw, S
Barton, M
Citation: W. Goettsch et al., Increased expression of endothelin-1 and inducible nitric oxide synthase isoform II in aging arteries in vivo: Implications for atherosclerosis, BIOC BIOP R, 280(3), 2001, pp. 908-913
Authors:
Barton, M
Vos, I
Shaw, S
Boer, P
D'uscio, LV
Grone, HJ
Rabelink, TJ
Lattmann, T
Moreau, P
Luscher, TF
Citation: M. Barton et al., Dysfunctional renal nitric oxide synthase as a determinant of salt-sensitive hypertension: Mechanisms of renal artery endothelial dysfunction and role of endothelin for vascular hypertrophy and glomerulosclerosis, J AM S NEPH, 11(5), 2000, pp. 835-846
Authors:
O'Brien, P
Roos, D
Pratt, G
Liew, K
Barton, M
Poulsen, M
Olver, I
Trotter, G
Citation: P. O'Brien et al., Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma, J CL ONCOL, 18(3), 2000, pp. 519-526
Citation: M. Burkhardt et al., Receptor- and non-receptor-mediated clearance of big-endothelin and endothelin-1: differential effects of acute and chronic ETA receptor blockade, J HYPERTENS, 18(3), 2000, pp. 273-279
Authors:
Barton, M
Carmona, R
Morawietz, HM
d'Uscio, LV
Goettsch, W
Hillen, H
Haudenschild, CC
Krieger, JE
Munter, K
Lattmann, T
Luscher, TF
Shaw, S
Citation: M. Barton et al., Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo - Evidence for a regulatory role of endothelin, HYPERTENSIO, 35(1), 2000, pp. 329-336
Authors:
Barton, M
Lattmann, T
d'Uscio, LV
Luscher, TF
Shaw, S
Citation: M. Barton et al., Inverse regulation of endothelin-1 and nitric oxide metabolites in tissue with aging: Implications for the age-dependent increase of cardiorenal disease, J CARDIO PH, 36, 2000, pp. S153-S156
Authors:
d'Uscio, LV
Barton, M
Shaw, S
Luscher, TF
Citation: Lv. D'Uscio et al., Endothelin in atherosclerosis: Importance of risk factors and therapeutic implications, J CARDIO PH, 35, 2000, pp. S55-S59
Authors:
Schober, T
Szot, K
Barton, M
Kessler, B
Breuer, U
Penkalla, HJ
Speier, W
Citation: T. Schober et al., Cation loss of BaCa0.393Nb0.606O2.91 in aqueous media: Amorphization at room temperature, J SOL ST CH, 149(2), 2000, pp. 262-275
Authors:
Morawietz, H
Szibor, M
Goettsch, W
Bartling, B
Barton, M
Shaw, S
Koerfer, R
Zerkowski, HR
Holtz, J
Citation: H. Morawietz et al., Deloading of the left ventricle by ventricular assist device normalizes increased expression of endothelin ETA receptors but not endothelin-converting enzyme-1 in patients with end-stage heart failure, CIRCULATION, 102(19), 2000, pp. 188-193
Citation: Tf. Luscher et M. Barton, Endothelins and endothelin receptor antagonists - Therapeutic considerations for a novel class of cardiovascular drugs, CIRCULATION, 102(19), 2000, pp. 2434-2440